ARTICLE | Company News
GSK's Weber to become COO at Takeda
December 3, 2013 1:45 AM UTC
Takeda Pharmaceutical Co. Ltd. (Tokyo:4502) named Christophe Weber COO, a newly created position. Weber -- who is president and general manager of the GSK Vaccines unit of GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) and CEO of GSK Biologicals S.A. -- is expected to join Takeda as COO by April 2014. ...